vTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update

December 15, 2023

https://www.globenewswire.com/news-release/2023/11/09/2777910/0/en/vTv-Therapeutics-Announces-2023-Third-Quarter-Financial-Results-and-Provides-Corporate-Update.html

HIGH POINT, N.C., Nov. 09, 2023 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq:VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin (TTP399) as an adjunctive therapy to insulin for the treatment of type 1 diabetes (“T1D”), today reported financial results for the third quarter ended September 30, 2023 and provided an update on recent corporate developments.

Read more at globenewswire.com

Related news for (VTVT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.